16:15:32 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



Numinus Wellness Inc
Symbol NUMI
Shares Issued 316,455,100
Close 2024-04-08 C$ 0.115
Market Cap C$ 36,392,337
Recent Sedar Documents

Numinus to release Q2 2024 results April 15

2024-04-09 10:37 ET - News Release

An anonymous director reports

NUMINUS TO HOST Q2 FISCAL 2024 RESULTS CONFERENCE CALL ON APRIL 15, 2024

Numinus Wellness Inc. will release its financial results for the quarter ended Feb. 29, 2024, after market close on Monday, April 15, 2024.

Interested parties are invited to participate in the company's Q2 2024 results conference call and webcast, which will be held on the same day at 5:30 p.m. Eastern Time/2:30 p.m. Pacific Time. During the call, Numinus executives will review the company's performance and recent initiatives.

A question-and-answer session will follow management's prepared remarks. At this time, the operator will provide instructions for qualified equity analysts to submit questions. Investors are invited to submit questions by e-mail to invest@numinus.com. A selection of questions will be answered by management on the call, and all e-mailed questions will be responded to by e-mail.

To listen to the live webcast, please register on-line.

The webcast will also be archived on the events and presentations page of Numinus's investor relations website.

To participate in the live conference call, please use the following dial-in information:

  • 1-888-330-3632 (toll-free North America);
  • 1-646-960-0837 (international);
  • Ask to participate in Numinus's Q2 2024 results call.

To avoid any delays in joining the call, please dial in at least five minutes before the call starts. If prompted, please provide conference passcode 3547386.

About Numinus Wellness Inc.

Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model -- including psychedelic research, clinic care and practitioner training -- is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, the company is leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

© 2024 Canjex Publishing Ltd. All rights reserved.